FUSCO, ALESSIO
FUSCO, ALESSIO
Role of serum-free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma
2022 Tacchetti P.; Rocchi S.; Zamagni E.; Barbato S.; Rizzello I.; De Cicco G.; Pantani L.; Mancuso K.; Fusco A.; Dozza L.; Ursi M.; Favero E.; Terragna C.; Testoni N.; Cavo M.
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study
2021 Rizzello, I.; Cavo, M.; Dozza, L.; Rivolti, E.; Petrucci, M. T.; De Stefano, V.; Antonioli, E.; Tosi, P.; D'Agostino, M.; More, S.; Gozzetti, A.; Cea, M.; Barbato, S.; Tacchetti, P.; Pantani, L.; Mancuso, K.; Rocchi, S.; De Cicco, G.; Fusco, A.; Zamagni, E.
Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma
2020 Mancuso K.; Tacchetti P.; Pantani L.; Rocchi S.; Rizzello I.; Caratozzolo I.; De Cicco G.; Fusco A.; Testoni N.; Terragna C.; Marzocchi G.; Martello M.; Borsi E.; Dozza L.; Cavo M.; Zamagni E.
Understanding how older age drives decision-making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patients
2019 Palandri, Francesca; Catani, Lucia; Auteri, Giuseppe; Bartoletti, Daniela; Fatica, Sofia; Fusco, Alessio; Bacchi Reggiani, Maria L; Cavo, Michele; Vianelli, Nicola
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Role of serum-free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma | Tacchetti P.; Rocchi S.; Zamagni E.; Barbato S.; Rizzello I.; De Cicco G.; Pantani L.; Mancuso K....; Fusco A.; Dozza L.; Ursi M.; Favero E.; Terragna C.; Testoni N.; Cavo M. | 2022-01-01 | AMERICAN JOURNAL OF HEMATOLOGY | - | 1.01 Articolo in rivista | American J Hematol - 2022 - Tacchetti - Role of serum‐free light chain assay for defining response and progression in.pdf |
| Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study | Rizzello, I.; Cavo, M.; Dozza, L.; Rivolti, E.; Petrucci, M. T.; De Stefano, V.; Antonioli, E.; T...osi, P.; D'Agostino, M.; More, S.; Gozzetti, A.; Cea, M.; Barbato, S.; Tacchetti, P.; Pantani, L.; Mancuso, K.; Rocchi, S.; De Cicco, G.; Fusco, A.; Zamagni, E. | 2021-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma | Mancuso K.; Tacchetti P.; Pantani L.; Rocchi S.; Rizzello I.; Caratozzolo I.; De Cicco G.; Fusco ...A.; Testoni N.; Terragna C.; Marzocchi G.; Martello M.; Borsi E.; Dozza L.; Cavo M.; Zamagni E. | 2020-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Understanding how older age drives decision-making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patients | Palandri, Francesca; Catani, Lucia; Auteri, Giuseppe; Bartoletti, Daniela; Fatica, Sofia; Fusco, ...Alessio; Bacchi Reggiani, Maria L; Cavo, Michele; Vianelli, Nicola | 2019-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |